Furthermore, inhibiting PI3K/mTOR has been found to remodel the tumor microenvironment and sensitize pS6high uterine leiomyosarcoma to PD-1 blockade, suggesting new therapeutic approaches [188]. Here, PDCD1 is linked to neoplasm.